Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 2 | 2023 | 29 | 1.390 |
Why?
|
| Atrial Fibrillation | 4 | 2021 | 23 | 0.990 |
Why?
|
| Hospital Mortality | 4 | 2022 | 30 | 0.920 |
Why?
|
| Sex Characteristics | 2 | 2021 | 36 | 0.820 |
Why?
|
| Terminal Care | 1 | 2023 | 4 | 0.770 |
Why?
|
| Defibrillators, Implantable | 1 | 2021 | 4 | 0.680 |
Why?
|
| Coronavirus | 1 | 2021 | 2 | 0.680 |
Why?
|
| Humans | 21 | 2024 | 5837 | 0.570 |
Why?
|
| Myocardial Infarction | 3 | 2022 | 21 | 0.490 |
Why?
|
| Female | 16 | 2024 | 3346 | 0.480 |
Why?
|
| Cardiovascular Diseases | 3 | 2024 | 77 | 0.470 |
Why?
|
| Hospitalization | 3 | 2021 | 86 | 0.460 |
Why?
|
| Male | 11 | 2022 | 3399 | 0.380 |
Why?
|
| Middle Aged | 9 | 2024 | 1775 | 0.330 |
Why?
|
| Aged | 8 | 2024 | 1860 | 0.290 |
Why?
|
| Biomarkers | 3 | 2024 | 141 | 0.280 |
Why?
|
| Retrospective Studies | 3 | 2022 | 584 | 0.220 |
Why?
|
| Illinois | 2 | 2021 | 52 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2024 | 25 | 0.200 |
Why?
|
| Age Factors | 2 | 2021 | 181 | 0.200 |
Why?
|
| Death | 1 | 2023 | 11 | 0.190 |
Why?
|
| Palliative Care | 1 | 2023 | 16 | 0.190 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2022 | 2 | 0.190 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2022 | 6 | 0.190 |
Why?
|
| Electric Countershock | 2 | 2006 | 4 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 9 | 0.180 |
Why?
|
| Logistic Models | 2 | 2021 | 109 | 0.180 |
Why?
|
| Quality of Life | 1 | 2023 | 108 | 0.180 |
Why?
|
| Troponin | 1 | 2021 | 7 | 0.170 |
Why?
|
| Sexism | 1 | 2021 | 5 | 0.170 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 2 | 0.170 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2021 | 4 | 0.170 |
Why?
|
| Physicians, Women | 1 | 2021 | 10 | 0.170 |
Why?
|
| Cardiology | 1 | 2021 | 13 | 0.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2021 | 1 | 0.170 |
Why?
|
| Risk Adjustment | 1 | 2021 | 1 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 14 | 0.170 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 8 | 0.170 |
Why?
|
| Ventricular Fibrillation | 1 | 2021 | 9 | 0.170 |
Why?
|
| Cognition | 1 | 2024 | 337 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 4 | 0.170 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 15 | 0.170 |
Why?
|
| Leadership | 1 | 2021 | 29 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 51 | 0.170 |
Why?
|
| Comorbidity | 1 | 2021 | 98 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2021 | 55 | 0.160 |
Why?
|
| Catheter Ablation | 1 | 2020 | 7 | 0.160 |
Why?
|
| Societies, Medical | 1 | 2020 | 21 | 0.160 |
Why?
|
| Stroke | 1 | 2021 | 71 | 0.160 |
Why?
|
| Electrocardiography | 2 | 2006 | 14 | 0.160 |
Why?
|
| Risk Factors | 5 | 2024 | 499 | 0.160 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1998 | 3 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 1998 | 5 | 0.140 |
Why?
|
| Graft Rejection | 1 | 1998 | 13 | 0.140 |
Why?
|
| Treatment Refusal | 1 | 2018 | 2 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2018 | 21 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2018 | 44 | 0.140 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 1034 | 0.140 |
Why?
|
| United States | 5 | 2021 | 502 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 69 | 0.130 |
Why?
|
| Diet Surveys | 1 | 2017 | 9 | 0.130 |
Why?
|
| Nutrition Assessment | 1 | 2017 | 18 | 0.130 |
Why?
|
| Diet, Mediterranean | 1 | 2017 | 19 | 0.120 |
Why?
|
| Heart Atria | 1 | 1996 | 6 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2013 | 21 | 0.100 |
Why?
|
| Life Style | 1 | 2013 | 48 | 0.100 |
Why?
|
| Patient Selection | 1 | 2013 | 48 | 0.100 |
Why?
|
| Health Promotion | 1 | 2013 | 44 | 0.090 |
Why?
|
| Motor Activity | 1 | 2013 | 83 | 0.090 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 203 | 0.080 |
Why?
|
| Time Factors | 3 | 2021 | 374 | 0.080 |
Why?
|
| Registries | 2 | 2022 | 45 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 13 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2024 | 25 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 309 | 0.050 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2022 | 2 | 0.050 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2022 | 7 | 0.050 |
Why?
|
| Echocardiography | 2 | 2006 | 12 | 0.050 |
Why?
|
| Recurrence | 2 | 2006 | 52 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2000 | 136 | 0.040 |
Why?
|
| Peripartum Period | 1 | 2021 | 1 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 54 | 0.040 |
Why?
|
| Patient Care Management | 1 | 2021 | 9 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 138 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 112 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 46 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 103 | 0.040 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 235 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 187 | 0.040 |
Why?
|
| Adult | 2 | 2017 | 1670 | 0.040 |
Why?
|
| Heart Rate | 1 | 2000 | 25 | 0.040 |
Why?
|
| Sleep Apnea, Central | 1 | 2000 | 23 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 31 | 0.040 |
Why?
|
| Psychology | 1 | 2018 | 5 | 0.040 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 13 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2018 | 54 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2018 | 34 | 0.030 |
Why?
|
| Cancer Survivors | 1 | 2018 | 4 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 49 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 47 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 406 | 0.030 |
Why?
|
| Diet, Western | 1 | 2017 | 3 | 0.030 |
Why?
|
| Obesity | 1 | 2018 | 81 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 163 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 111 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 333 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 421 | 0.030 |
Why?
|
| Prospective Studies | 1 | 1996 | 411 | 0.030 |
Why?
|
| Social Networking | 1 | 2013 | 5 | 0.020 |
Why?
|
| Efficiency | 1 | 2013 | 9 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 20 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 30 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2013 | 44 | 0.020 |
Why?
|
| Chicago | 1 | 2013 | 239 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 1991 | 1 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 32 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2006 | 71 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2000 | 4 | 0.010 |
Why?
|
| Respiration | 1 | 2000 | 7 | 0.010 |
Why?
|
| Tracheostomy | 1 | 2000 | 4 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2000 | 14 | 0.010 |
Why?
|
| Anesthesia | 1 | 2000 | 13 | 0.010 |
Why?
|
| Child | 1 | 2000 | 339 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1991 | 2 | 0.010 |
Why?
|
| Equipment Design | 1 | 1991 | 38 | 0.010 |
Why?
|